These therapies may represent an alternative approach to insulin, pancreas and pancreatic islet transplantations in the treatment of patients with type 1 diabetes mellitus (T1D), and adult stem cells (such as hematopoietic and mesenchymal stem cells) represent an attractive and promising tool for this purpose [2,3]. The gene discussed is INS; the disease is type 1 diabetes mellitus.